Immucor Inc. (NASDAQ:BLUD) of Norcross, Ga., on Monday said itplans to acquire BCI-Human, its Italian distributor. Terms ofthe deal, which is subject to a definitive agreement, were notdisclosed. BCI, which buys about $400,000 worth of Immucorproducts annually, would be run by its existing management.About one-third of its $3.2 million in revenues comes fromsales of the Immucor product line. Immucor makes blood bankreagents and systems.
(c) 1997 American Health Consultants. All rights reserved.